Last updated on August 2017

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir Dasabuvir Ribavirin in Patients With Chronic Hepatitis C in Colombia


Brief description of study

The interferon-free combination regimen of Paritaprevir/r - Ombitasvir with or without Dasabuvir (ABBVIE REGIMEN) ± Ribavirin (RBV) for the treatment of chronic hepatitis C (CHC) has been shown to be safe and effective in randomized controlled clinical trials with strict inclusion and exclusion criteria under well controlled conditions. This observational study is the first effectiveness research examining the ABBVIE REGIMEN ± RBV, used according to local label, under real world conditions in Israel in a clinical practice patient population.

Clinical Study Identifier: NCT02851069

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Angela Paola Duarte, MS

Fundacion Santa Fe de Bogota /ID# 155736
Bogota, Colombia
  Connect »

Angela Paola Duarte, MS

Fundacion Cardioinfantil /ID# 155724
Bogota, Colombia
  Connect »

Angela Paola Duarte, MS

Medplus Medicia Prepagada /ID# 163985
Bogota, Colombia
  Connect »

Angela Paola Duarte, MS

Cic Cali /Id# 163986
Cali, Colombia
  Connect »

Angela Paola Duarte, MS

Centro Medico Imbanaco /ID# 163660
Cali, Colombia
  Connect »

Angela Paola Duarte, MS

Fundacion Valle Del Lili /ID# 155723
Cali, Colombia
  Connect »

Angela Paola Duarte, MS

Pharos Centro de Estudios Clinicos /ID# 161709
Cartagena, Colombia
  Connect »

Angela Paola Duarte, MS

Ips Medicos Internistas Del Caldas /Id# 163987
Manizales, Colombia
  Connect »

Angela Paola Duarte, MS

Fundacion Hospitalaria San Vincente de Paul /ID# 167437
Medellin, Colombia
  Connect »

Angela Paola Duarte, MS

IPS Universitaria /ID# 155725
Medellin, Colombia
  Connect »

Angela Paola Duarte, MS

Hospital Pablo Tobon Uribe /ID# 155722
Medellin, Colombia
  Connect »